Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.
Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.
Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.
American Shared Hospital Services (AMS) announced its Annual Meeting of Shareholders will take place on June 20, 2023, at 9:00 a.m. PT, both virtually and in-person at the Hilton Hotel in San Francisco, CA. The record date for determining eligible shareholders is set for April 24, 2023. AMS is a prominent provider of technology solutions for stereotactic radiosurgery and advanced radiation therapy, focusing on cancer treatment facilities. The company collaborates with major OEMs to offer advanced medical equipment, including MR Guided Radiation Therapy Linacs and Proton Beam Therapy Systems. AMS highlights its Gamma Knife radiosurgery equipment for non-invasive tumor treatment. The firm also issued a safe harbor statement discussing potential risks affecting its financial outlook.